Vis enkel innførsel

dc.contributor.authorDimka, Jessica
dc.date.accessioned2023-11-28T07:06:35Z
dc.date.available2023-11-28T07:06:35Z
dc.date.created2023-11-26T19:25:05Z
dc.date.issued2023
dc.identifier.citationVaccine. 2023, 14 .en_US
dc.identifier.issn0264-410X
dc.identifier.urihttps://hdl.handle.net/11250/3104877
dc.description.abstractPeople with disabilities and chronic health conditions are at higher risk of poor outcomes to COVID-19, yet may have lower rates of vaccination due to differences in prioritization strategies, accessibility issues, vaccine hesi- tancy, and other factors. Survey data from Oslo are used to investigate differences in self-reported vaccine offer, uptake, and hesitancy, as well as COVID-19 infection, for individuals with self-reported medical risk factors classified as chronic health conditions or disabilities according to likely societal perceptions. Compared to participants who reported no pre-existing medical conditions, people with chronic health conditions were more likely to have a confirmed diagnosis, be offered and take the vaccine, and have lower hesitancy, while people with disabilities generally had either no differences in or less optimal outcomes. Results suggest possible biases in vaccine recommendations and raise questions about accessibility and communication strategies, with important implications for pandemic preparedness and public health communication and practice.en_US
dc.language.isoengen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/deed.no*
dc.titleCOVID-19 vaccination and infection among people with self-reported chronic health conditions and disabilities vs. people without medical risk factors in a survey sample from Osloen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doihttps://doi.org/10.1016/j.jvacx.2023.100409
dc.identifier.cristin2202417
dc.source.journalVaccineen_US
dc.source.volume14en_US
dc.source.pagenumber4en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal